FAZMYO
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Oct 2025)
What this means for you
This application is over — abandoned 09 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97388509
- Mark type
- Stylized text
- Filed
- 29 Apr 2022
- Published for opposition
- 03 Jan 2023
- Abandoned
- 09 Oct 2025
- Attorney of record
- Gina A. Bibby
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy
Owner
- Fulcrum Therapeutics, Inc., Cambridge, MA, US
- Fulcrum Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 09 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2024 — SOU EXTENSION 3 GRANTED
- 09 Jul 2024 — SOU EXTENSION 3 FILED
- 09 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 23 Feb 2024 — ITU LETTER MAILED, NO RESPONSE REQUIRED
- 23 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 06 Feb 2024 — SOU EXTENSION 2 GRANTED
- 06 Feb 2024 — SOU EXTENSION 2 FILED
- 06 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Dec 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 18 Dec 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED